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The active-site residues of indoleglycerol-phosphate synthase from Escherichia coli were tentatively localized by compar- 
ing crystallographic data with the amino acid identities among the known indoleglycerol-phosphate synthase sequences. 
To test the validity of the resulting model of catalysis one of the residues in the presumptive active site, Lys 55, was 
changed to serine using oligonucleotide-directed mutagenesis. The specificity constant k-,/K, of the mutant is 3 x l(P- 
times lower than that of the wild-type enzyme, due to a 60-fold decrease in k,, and a 450-fold increase in K,,,. This finding 
shows that Lys 55 is important for both catalysis and substrate binding. 
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1. INTRODUCTION 
The bifunctional enzyme phosphoribosyl- 
anthranilate isomerase : indoleglycerol-phosphate 
synthase (PRA isomerase : IGP synthase, EC 
4.1.1.48) of Escherichiu co/i catalyzes two sequen- 
tial steps in the biosynthesis of tryptophan (fig. 1). 
Both biochemical and genetic studies have shown 
that the amino-terminal half of the protein 
catalyzes the IGP synthase reaction, whereas the 
carboxyl-terminal half is responsible for the PRA 
isomerase activity [l-3]. The crystal structure of 
the enzyme shows that the two activities reside on 
two well-separated omains [4]. Each domain has 
the folding pattern of triosephosphate isomerase 
[5], namely that of an 8-fold ,&Y barrel. 
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More highly resolved structural information is 
necessary to propose a realistic mechanism for the 
catalytic process. However, the availability of 10 
homologous amino acid sequences helps in identi- 
fying residues in the E. co/i sequence that are likely 
to be involved in catalysis [4]. Here, one of these, 
Lys 55, has been chosen for analysis by oligo- 
nucleotide-directed mutagenesis. 
2. MATERIALS AND METHODS 
2. I. Materials 
Oligonucleotides were synthesized automatically (Applied 
Biosystems 380B, phosphoramidite method) and purified by 
reverse-phase HPLC (Beckman HPLC, WaterspBondpak C-18 
column). Restriction enzymes and DNA-modifying enzymes 
were from Boehringer, BRL and Pharmacia. Gel 
chromatography materials were from Pharmacia and radio- 
chemicals from Amersham. 
2.2. E. coli strains, plasmids and phages 
E. coli W3310 trpR AtrpEA [6] harbouring the pWS1 plasmid 
[6] was used to produce both wild-type and mutant IGP syn- 
thase:PRA isomerase. E. coli W3310 trpC9800 recAs6 
Tc’: Tn: 10 [2], which is phenotypically trpC_ trpF+, was used 
to check for complementation i vivo. The strains BMH 71-18, 
BMH 71-18 mutS, MK 30-3 [7], and the phages M13mp9trpC(F) 
[8], M13mp9rev [7] were used for site-directed mutagenesis. 
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Fig. 1. Metabolic reactions catalyzed by PRA isomerase and IGP 
synthase. 
2.3. Oligonucleotide-directed mutagenesis 
Site-directed mutagenesis was carried out with the gapped 
duplex strategy [7]. 5’-Phosphorylation was performed ac- 
cording to [9). Mutants were screened by dot-blot hybridization 
[9], restriction analysis and sequencing [lo]. A fragment con- 
taining the mutated region was isolated from the replicative 
form of the recombinant M13mp9 phage, and used to substitute 
the corresponding region of the trpC(F) gene in pWS1 expres- 
sion vector 161. 
2.4. Purification of IGP synthase: PRA isomerase 
Mutant IGP synthase: PRA isomerase was purified as in [11] 
with the following modifications: E. coli W3310 trpR AtrpEA 
[6] harbouring pWS1 [6] was grown for 16 h in LB medium con- 
taining 30 mg/l chloramphenicol]l2] with good aeration. 310 g 
cells were harvested from 35 1 of culture by centrifugation, 
washed with 50 mM Tris-Cl (pH 8.5) and opened in 50 mM 
Tris-Cl (pH 8.5), 5 mM EDTA, 1 mM DTE, 0.1 mM PMSF 
and 5 mM serine, using a Sonicator cell disruptor (model W 
375) with two pulses of duration 2 min each at maximum 
amplitude. The homogenate was cleared by centrifugation and 
DNA was precipitated with protamine sulfate solution (10 ml of 
5% solution per g DNA). The supernatant (310 ml containing 
8.7 g protein) was applied to a column of Q-Sepharose fast flow 
(Pharmacia, 1100 ml gel volume), which was equilibrated with 
50 mM Tris-Cl (pH 8.0), 5 mM EDTA, 1 mM DTE and 
0.1 mM PMSF. Protein was eluted with a linear gradient of 
50-350 mM NaCl in the above buffer (2700 ml total gradient 
volume). PRA isomerase activity appeared at 150 mM NaCl. 
Active fractions were dialysed vs 20 mM potassium phosphate, 
pH 7.5 (final volume 190 ml, 440 mg protein), and pumped on- 
to a column of DEAE-Sepharose fast flow (Pharmacia, 800 ml 
gel volume). A linear gradient of 20-300 mM potassium phos- 
phate (pH 7.5) was applied. PRA isomerase activity appeared at 
180 mM potassium phosphate. Active fractions were concen- 
trated either by ultrafiltration (Amicon PM-10 membrane) or 
precipitation with ammonium sulfate at 70% saturation, and 
loaded in two batches (1.6 ml each) onto a column of Sephacryl 
S-200 (Pharmacia, 140 ml gel volume) equilibrated with 
100 mM potassium phosphate (pH 7.0), 5 mM EDTA, 1 mM 
DTE. PRA isomerase activity appeared at 78 ml elution 
volume. 
2.5. Enzyme assays 
IGP synthase and PRA isomerase activities were measured as 
described [11,13]. 
3. RESULTS 
The amino acid sequence alignment of IGP syn- 
thase from several organisms shows that identical 
amino acids are clustered within the carboxyl- 
terminal halves of the p-strands and the following 
loops [4]. The homology is particularly pronounc- 
ed in the first P-strand-loop junction where 
Glu 53, Lys 55, Ala 57, Pro 59, Ser 60 and Gly 62 
are 100% conserved. Moreover, the substrate 
analogue 5-iodo-rCdRP binds to this highly con- 
served region [4]. In contrast, both the amino- 
terminal halves of the&strands and the external (Y- 
helices are significantly less conserved. These 
observations uggest that the active site of IGP syn- 
thase lies at the carboxyl end of the eight parallel ,& 
strands and that the first &strand including the 
following loop plays an important role. 
No cofactors or metal ions have been identified 
as essential for catalysis [14]. Moreover, no 
covalent enzyme-substrate complexes have been 
observed [15]. A kinetic mechanism for IGP syn- 
thase has been established but the chemical step 
that requires a protonated amino acid side chain 
with an apparent pKa value of about 7 has not been 
resolved into intermediates [ 151. Conserved 
histidine residues, which might explain the pH 
dependence of the chemical step, are absent from 
the active site. 
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Fig.2 presents a plausible chemical mechanism 
for the cyclization reaction catalyzed by IGP syn- 
thase. There are two completely conserved residues 
sufficiently close to the reacting atoms of CdRP for 
catalytic assistance: Lys 55 and Arg 186. One out 
of several models views Arg 186 as an ion-pair 
partner of the substrate’s carboxyl group, and 
Lys 55 as proton donor interacting with the sub- 
strate’s carbonyl group. In order to check the im- 
portance of Lys 55 in catalysis, its side chain was 
eliminated by replacing Lys 55 with Ser, using site- 
directed mutagenesis [7]. The mutant gene was ex- 
pressed in E. coli [ 171, the corresponding protein 
purified to homogeneity, and its catalytic proper- 
ties analyzed kinetically. Table 1 lists the steady- 
state parameters of both the wild-type and mutant 
enzymes. The Km value of the PRA isomerase reac- 
opog 
lndoleglycerol phosphate 
Fig.2. Proposed chemical catalysis of IGP synthase. In a 
modified version of Rawn’s proposal [la], a cyclic intermediate 
is formed by concerted decarboxylation and carbon-to-carbon 
bond formation. This intermediate is converted to the indole 
ring formally by release of OH-. 
Table 1 
Steady-state parameters of IGP synthase: PRA isomerase wild- 
type and K55S mutant 
Reaction Enzyme k cat KIU k cat 
(s-l) @M) (rrM-‘.s-‘) 
PRA isomerase wild-type 38.9 7.1 5.5 
K55S mutant 22.1 7.1 3.1 
IGP synthase wild-type 7.2 1.2 6.0 
K55S mutant 0.12 540 2.2 x lo+ 
The PRA isomerase reaction was measured in 50 mM Tris-Cl 
(pH 7.5), 4 mM MgClr, 2 mM DTE, at 25°C [13]. IGP synthase 
activities were measured in 100 mM Tric-Cl (pH 7.8), 5 mM 
EDTA, 1 mM DTE, at 37°C Ill]. Km and kcat were determined 
using the direct linear plot method [19] 
tion is the same for both wild-type and mutant en- 
zymes. It is not clear whether the 2-fold difference 
in kcat is due to the mutation in the adjacent do- 
main or to partial inactivation. Nevertheless, it ap- 
pears that the integrity of the PRA isomerase do- 
main is not affected significantly by the mutation. 
In contrast, kcat of IGP synthase is decreased by a 
factor of 60, and K,,, is increased by a factor of 450, 
resulting in a 3 x 104-fold decrease in k,,JK,,, com- 
pared to the wild-type enzyme. 
4. DISCUSSION 
Assuming that the structure of IGP synthase has 
not been altered apart from the change of Lys 55 to 
Ser, these results show that the side chain of Lys 55 
stabilizes both the enzyme-substrate complex and 
the enzyme-transition state complex to a similar ex- 
tent. The relatively small decrease in kcat indicates 
that Lys 55 stabilizes the transition state somewhat 
more than the ground state of the enzyme-bound 
substrate [18]. Although Lys 55 is clearly impor- 
tant in catalysis, it is not essential. It is not clear 
whether Lys 55 acts as a general acid or as a part- 
ner for electrostatic interactions tabilizing the lone 
electron pair of the intermediate in fig.2. In the 
former, the intrinsic pK, value of the e-amino 
group of Lys 55 would have to be decreased by 3 
units. 
The replacement of other conserved residues is 
currently being undertaken in order to gain further 
insight into the catalytic mechanism of IGP syn- 
thase. 
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